CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

In another China pact, Lilly makes a deal with InnoCare worth up to $3.35B

PartnershipPositive
AI Analysis

Summary

Eli Lilly and Beijing-based InnoCare have entered into a partnership agreement for drug development with a potential deal value of up to $3.35 billion if the products reach commercialization.

Importance:7/10
Sentiment:
0.60
partnershipChinadrug developmentlicensing deal
Related Companies

Read the original article

Published by Endpoints News on September 24, 2026 9:59 AM

Read Original